185 related articles for article (PubMed ID: 31567536)
1. Positive effect of metformin treatment in colorectal cancer patients with type 2 diabetes: national cohort study.
Dulskas A; Patasius A; Linkeviciute-Ulinskiene D; Zabuliene L; Urbonas V; Smailyte G
Eur J Cancer Prev; 2020 Jul; 29(4):289-293. PubMed ID: 31567536
[TBL] [Abstract][Full Text] [Related]
2. Reduced risk of prostate cancer in a cohort of Lithuanian diabetes mellitus patients.
Kincius M; Patasius A; Linkeviciute-Ulinskiene D; Zabuliene L; Smailyte G
Aging Male; 2020 Dec; 23(5):1333-1338. PubMed ID: 32410514
[TBL] [Abstract][Full Text] [Related]
3. A Cohort Study of Metformin and Colorectal Cancer Risk among Patients with Diabetes Mellitus.
Bradley MC; Ferrara A; Achacoso N; Ehrlich SF; Quesenberry CP; Habel LA
Cancer Epidemiol Biomarkers Prev; 2018 May; 27(5):525-530. PubMed ID: 29716927
[No Abstract] [Full Text] [Related]
4. Metformin is associated with a lower risk of colorectal cancer in Taiwanese patients with type 2 diabetes: A retrospective cohort analysis.
Tseng CH
Diabetes Metab; 2017 Oct; 43(5):438-445. PubMed ID: 28438547
[TBL] [Abstract][Full Text] [Related]
5. Increased kidney cancer risk in diabetes mellitus patients: a population-based cohort study in Lithuania.
Undzyte G; Patasius A; Linkeviciute-Ulinskiene D; Zabuliene L; Stukas R; Dulskas A; Smailyte G
Aging Male; 2020 Dec; 23(5):1241-1245. PubMed ID: 32342709
[TBL] [Abstract][Full Text] [Related]
6. Metformin significantly reduces incident prostate cancer risk in Taiwanese men with type 2 diabetes mellitus.
Tseng CH
Eur J Cancer; 2014 Nov; 50(16):2831-7. PubMed ID: 25201464
[TBL] [Abstract][Full Text] [Related]
7. Metformin increases cancer specific survival in colorectal cancer patients-National cohort study.
Dulskas A; Patasius A; Linkeviciute-Ulinskiene D; Zabuliene L; Urbonas V; Smailyte G
Cancer Epidemiol; 2019 Oct; 62():101587. PubMed ID: 31491730
[TBL] [Abstract][Full Text] [Related]
8. Insulin enhances and metformin reduces risk of colorectal carcinoma in type-2 diabetes.
Chen CH; Lin CL; Hsu CY; Kao CH
QJM; 2020 Mar; 113(3):194-200. PubMed ID: 31593243
[TBL] [Abstract][Full Text] [Related]
9. The impact of metformin on survival in patients with melanoma-national cohort study.
Urbonas V; Rutenberge J; Patasius A; Dulskas A; Burokiene N; Smailyte G
Ann Epidemiol; 2020 Dec; 52():23-25. PubMed ID: 32980534
[TBL] [Abstract][Full Text] [Related]
10. Metformin use is associated with a decreased incidence of colorectal adenomas in diabetic patients with previous colorectal cancer.
Lee JH; Jeon SM; Hong SP; Cheon JH; Kim TI; Kim WH
Dig Liver Dis; 2012 Dec; 44(12):1042-7. PubMed ID: 22789400
[TBL] [Abstract][Full Text] [Related]
11. Increased Risk of Site-Specific Cancer in People with Type 2 Diabetes: A National Cohort Study.
Linkeviciute-Ulinskiene D; Patasius A; Zabuliene L; Stukas R; Smailyte G
Int J Environ Res Public Health; 2019 Dec; 17(1):. PubMed ID: 31905811
[TBL] [Abstract][Full Text] [Related]
12. Metformin's role in lowering colorectal cancer risk among individuals with diabetes from the Southern Community Cohort Study.
Lawler T; Walts ZL; Giurini L; Steinwandel M; Lipworth L; Murff HJ; Zheng W; Warren Andersen S
Cancer Epidemiol; 2024 Jun; 90():102566. PubMed ID: 38518387
[TBL] [Abstract][Full Text] [Related]
13. No reduced risk of overall, colorectal, lung, breast, and prostate cancer with metformin therapy in diabetic patients: database analyses from Germany and the UK.
Kowall B; Stang A; Rathmann W; Kostev K
Pharmacoepidemiol Drug Saf; 2015 Aug; 24(8):865-74. PubMed ID: 26132313
[TBL] [Abstract][Full Text] [Related]
14. Metformin reduces ovarian cancer risk in Taiwanese women with type 2 diabetes mellitus.
Tseng CH
Diabetes Metab Res Rev; 2015 Sep; 31(6):619-26. PubMed ID: 25820555
[TBL] [Abstract][Full Text] [Related]
15. Type 2 diabetes increases and metformin reduces total, colorectal, liver and pancreatic cancer incidences in Taiwanese: a representative population prospective cohort study of 800,000 individuals.
Lee MS; Hsu CC; Wahlqvist ML; Tsai HN; Chang YH; Huang YC
BMC Cancer; 2011 Jan; 11():20. PubMed ID: 21241523
[TBL] [Abstract][Full Text] [Related]
16. Metformin and Gastrointestinal Cancer Development in Newly Diagnosed Type 2 Diabetes: A Population-Based Study in Korea.
You JH; Song SO; Kang MJ; Cho YY; Kim SW; Suh SH; Lee S; Lee YH; Lee BW
Clin Transl Gastroenterol; 2020 Nov; 11(11):e00254. PubMed ID: 33105165
[TBL] [Abstract][Full Text] [Related]
17. Metformin usage and the risk of colorectal cancer: a national cohort study.
Lee JW; Choi EA; Kim YS; Kim Y; You HS; Han YE; Kim HS; Bae YJ; Kim J; Kang HT
Int J Colorectal Dis; 2021 Feb; 36(2):303-310. PubMed ID: 32968891
[TBL] [Abstract][Full Text] [Related]
18. Metformin may reduce bladder cancer risk in Taiwanese patients with type 2 diabetes.
Tseng CH
Acta Diabetol; 2014 Apr; 51(2):295-303. PubMed ID: 24509842
[TBL] [Abstract][Full Text] [Related]
19. Reduced risk of colorectal cancer with metformin therapy in patients with type 2 diabetes: a meta-analysis.
Zhang ZJ; Zheng ZJ; Kan H; Song Y; Cui W; Zhao G; Kip KE
Diabetes Care; 2011 Oct; 34(10):2323-8. PubMed ID: 21949223
[TBL] [Abstract][Full Text] [Related]
20. Relationship between type-2 diabetes and use of metformin with risk of colorectal adenoma in an American population receiving colonoscopy.
Kanadiya MK; Gohel TD; Sanaka MR; Thota PN; Shubrook JH
J Diabetes Complications; 2013; 27(5):463-6. PubMed ID: 23755906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
